Neuraminidase from C. welchii
| Catalog number: | B2012826 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 1 Unit |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Acyl-neuraminyl Hydrolase, Receptor-destroying enzyme, Sialidase |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Air GM. Influenza neuraminidase Influenza Other Respir Viruses. 2012 Jul;6(4):245-56.
- Zhang JY, Chen QQ, Li J, Zhang L, Qi LW. Neuraminidase 1 and its Inhibitors from Chinese Herbal Medicines: An Emerging Role for Cardiovascular Diseases Am J Chin Med. 2021;49(4):843-862.
- Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen Curr Top Microbiol Immunol. 2009;333:227-41.
- Eichelberger MC, Wan H. Influenza neuraminidase as a vaccine antigen Curr Top Microbiol Immunol. 2015;386:275-99.
- Hammond AJ, Binsker U, Aggarwal SD, Ortigoza MB, Loomis C, Weiser JN. Neuraminidase B controls neuraminidase A-dependent mucus production and evasion PLoS Pathog. 2021 Apr 5;17(4):e1009158.
- Air GM, Ghate AA, Stray SJ. Influenza neuraminidase as target for antivirals Adv Virus Res. 1999;54:375-402.
- Matsushita T, Danyel MN, Koyama T, Hatano K, Matsuoka K. Neuraminidase-triggered activation of prodrug-type substrate of 4-nitroaniline Bioorg Med Chem Lett. 2020 Jan 15;30(2):126883.
- Hasov Z, Kok I, Ondrejovi M, Miertu S, Katrlk J. Methods and Current Trends in Determination of Neuraminidase Activity and Evaluation of Neuraminidase Inhibitors Crit Rev Anal Chem. 2019;49(4):350-367.
- Isaeva ES, Sokolov MI. [Orthomyxovirus neuraminidase] Vopr Virusol. 1974 Sep-Oct;(5):515-21.
